In our results, SLC14A1 high expression correlated with low IC50 values in blood cancer cell lines and acted as a good prognostic predictor in AML patients for both GSE12417 and TCGA CN-AML datasets. This evidence concerns the gene SLC14A1 and hematopoietic and lymphoid system neoplasm.